Related Experiment Video
Updated: May 10, 2026
09:11
Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
Published on: August 23, 2016
Interferon therapy prolonged life expectancy among chronic hepatitis C patients
Haruhiko Yoshida1, Yasuyuki Arakawa, Michio Sata
1Department of Gastroenterology, University of Tokyo Graduate School of Medicine, Bunkyo, Tokyo, Japan. yoshida-2im@h.u-tokyo.ac.jp
Gastroenterology
|July 30, 2002
Summary
Interferon therapy significantly improves survival in chronic hepatitis C patients. Treatment reduced liver-related deaths and overall mortality compared to untreated individuals.
Area of Science:
- Hepatology
- Viral Hepatitis
- Clinical Medicine
Background:
- Chronic hepatitis C (CHC) patient survival with interferon therapy remains unclear.
- A large cohort study was initiated to analyze survival outcomes in CHC patients.
Purpose of the Study:
- To evaluate the impact of interferon therapy on the survival rates of patients with chronic hepatitis C.
- To compare mortality risks between interferon-treated and untreated CHC patients.
Main Methods:
- Retrospective cohort study involving 2889 patients across 8 Japanese hospitals.
- Interferon therapy administered to 2430 patients; 459 served as an untreated control group.
- Survival analyzed using standardized mortality ratios and proportional hazards regression.
Main Results:
- Overall mortality was higher in untreated patients (SMR: 1.9) compared to the general population.
- Interferon therapy was associated with reduced overall death risk (RR: 0.367) and liver-related death risk (RR: 0.284).
- Sustained responders showed significantly lower mortality risks (RR: 0.148 for overall, 0.050 for liver-related).
Conclusions:
- Interferon therapy enhances survival in chronic hepatitis C patients.
- The primary benefit of interferon therapy is the prevention of liver-related mortality.
- Treatment efficacy is particularly pronounced in virologic sustained responders.
More Related Videos
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:23Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...